Tue, January 2, 2018
Tue, December 26, 2017
Fri, December 22, 2017
Thu, December 21, 2017
Wed, December 20, 2017
Tue, December 19, 2017
Mon, December 18, 2017
Fri, December 15, 2017
Thu, December 14, 2017
Wed, December 13, 2017
Tue, December 12, 2017
Mon, December 11, 2017
Fri, December 8, 2017
Thu, December 7, 2017
Wed, December 6, 2017
Tue, December 5, 2017
Mon, December 4, 2017
Fri, December 1, 2017
Thu, November 30, 2017
Wed, November 29, 2017
Tue, November 28, 2017
Mon, November 27, 2017
Wed, November 22, 2017
Tue, November 21, 2017
Mon, November 20, 2017
Fri, November 17, 2017

Robert Hazlett Initiated (AKBA) at Strong Buy and Held Target at $30 on, Dec 7th, 2017


//stocks-investing.news-articles.net/content/201 .. g-buy-and-held-target-at-30-on-dec-7th-2017.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Robert Hazlett of BTIG, Initiated "Akebia Therapeutics, Inc." (AKBA) at Strong Buy and Held Target at $30 on, Dec 7th, 2017.

Robert has made no other calls on AKBA in the last 4 months.



There is 1 other peer that has a rating on AKBA. Out of the 1 peers that are also analyzing AKBA, 0 agree with Robert's Rating of Hold.



This is the rating of the analyst that currently disagrees with Robert


  • Difei Yang of "Mizuho" Initiated at Strong Buy and Held Target at $24 on, Thursday, October 5th, 2017

Publication Contributing Sources